Thermo Fisher AI Strategy: ChatGPT for Staff and AI in Clinical Trials
How Thermo Fisher uses AI on its own work: an OpenAI collaboration, ChatGPT Enterprise for staff, AI in PPD clinical research and a Responsible AI Framework. Updated November 2026.
Scientific instruments, lab supplies, diagnostics and contract research and manufacturing, including PPD
Thermo Fisher has no standalone AI strategy document. Its approach comes from its October 2025 OpenAI announcement and 2025 remarks by its CIO.
Read the company sourceWhere Thermo Fisher Scientific Is Going with AI
Thermo Fisher is embedding AI across its operations, products and services, with OpenAI as a central partner. In October 2025, it announced a collaboration that brings ChatGPT Enterprise to its staff and OpenAI models into its PPD clinical research business. Thermo Fisher has no standalone AI strategy document, so this profile draws on that announcement and company pages.
The CEO frames AI as part of how the company runs. Chairman, President and CEO Marc Casper said: “With OpenAI, we’re further embedding AI across our operations, products and services.”
The focus has four parts.
- Clinical research: AI in PPD to shorten clinical trial cycle times and spot therapies unlikely to succeed sooner
- Everyday work: ChatGPT Enterprise and an internal generative AI platform for employees
- Software engineering: generative AI to raise the speed and quality of software work
- Content and operations: AI for content generation and operational efficiency
What It Takes: OpenAI, an Internal Platform and Responsible AI Governance
Thermo Fisher built governance before scaling. Ryan Snyder, Senior Vice President and Chief Information Officer, wrote in 2025 that the company built “a Responsible AI (RAI) Framework and set up an AI Technology Council” (Thermo Fisher). He added that it has “prioritized building enterprise-wide literacy and adoption.”
Employees are invited to experiment. Snyder said: “Our colleagues are empowered to explore how generative AI can help them in their day-to-day work.” Thermo Fisher also consolidated its automation, AI and data teams into a shared service for all divisions, according to PharmaSource.
Headcount has edged down. Thermo Fisher had about 125,000 employees at the end of 2025, down from about 130,000 in 2022. The sources reviewed do not link the change to AI.
AI fluency, coded against the Lead with AI Fluency Matrix (September 2026 edition):
- Fluency floor: Not published. Thermo Fisher prioritizes AI literacy across the company, but it has set no required level for all staff.
- Highest level evidenced: Level 2 (Collaborating), company-claimed. Employees use an internal generative AI platform for software engineering and content work. Thermo Fisher has published no results showing AI built into core workflows.
- Portfolio design: Thermo Fisher pairs a company-wide AI platform with a focused bet on clinical research, where trial speed drives value for customers.
How Thermo Fisher Scientific Measures Results
Thermo Fisher reports no AI results for its own work. It has published no adoption rates, time savings or cost figures for ChatGPT Enterprise, its internal platform or AI in PPD.
The goals can be measured. Shorter clinical trial cycle times and earlier calls on failing therapies both have clear metrics, and reporting them would be the step from AI adoption to AI value.
Next markers: adoption of ChatGPT Enterprise, trial cycle-time results from PPD, any AI savings in operations and headcount for 2026.
Change log
- 2025: Snyder describes Thermo Fisher’s internal generative AI platform, Responsible AI Framework and AI Technology Council.
- October 2025: Thermo Fisher announces an OpenAI collaboration, including ChatGPT Enterprise for staff.
The Bottom Line
- Disclosure: 3 of 4. Thermo Fisher answers where it is going, where it will focus and what it will take. It reports no AI results.
- OpenAI is the central partner, from staff tools to clinical research.
- Governance came first, with a Responsible AI Framework and an AI Technology Council.
- Level 2 is evidenced in software and content work.
- The say-do gap is measurement. Thermo Fisher sets clear AI goals but publishes no results.
- Watch PPD. The test is whether AI shortens clinical trials in ways Thermo Fisher reports.
Revenue, Headcount and Revenue per Employee
What the numbers show: Revenue fell 1% from 2022 to 2025 while headcount fell 4%, so revenue per employee rose 3%, to about $356,000. Revenue and headcount fell in 2023 as COVID-19 related demand faded, then recovered. These figures do not show that AI caused any change.
Revenue, headcount and revenue per employee, FY2022 to FY2025
- FY2022: $44.92bn revenue, 130,000 employees, $346k per employee
- FY2023: $42.86bn revenue, 122,000 employees, $351k per employee
- FY2024: $42.88bn revenue, 125,000 employees, $343k per employee
- FY2025: $44.56bn revenue, 125,000 employees, $356k per employee
Change, FY2022 to FY2025: revenue down 1%, headcount down 4%, revenue per employee up 3%.
Notes: Revenue is total revenues, as reported. Headcount is approximate, at December 31. Revenue in 2022 included COVID-19 related sales that fell away in 2023.
These figures give context on scale and productivity. They do not show that AI caused any change. Sources: Thermo Fisher Scientific 10-K filings.
How Thermo Fisher Scientific Compares with Medical Technology and Health Services Peers
We looked at how Thermo Fisher Scientific compares with other medical technology and health services companies in the index. Here is how they stack up.
| Company | Disclosure | AI owner | Fluency floor | Governance | AI value reported | Revenue per employee |
|---|---|---|---|---|---|---|
| Abbott | 3 of 4 | CIO; executive steering committee on generative AI | Not published; AI education for leaders | Steering committee; financial test for each AI investment | IT results committed, no figure | $385k |
| CVS Health | 4 of 4 | Chief Experience and Technology Officer | Not published | CEO sets where AI will and will not be used; no published framework | $1B+ savings from technology and AI, AI share not split | $1.34M |
| Danaher | 3 of 4 | CEO links AI to the Danaher Business System | Not published | Through DBS; AI listed as a risk factor | None published | $409k |
| EssilorLuxottica | 2 of 4 | No named AI owner | Not published | Little published | None published | $206k |
| Intuitive Surgical | 2 of 4 | VP of Enterprise Data, Analytics and AI | Not published | AI Governance Committee; published principles | None published | $591k |
| Medtronic | 4 of 4 | IT leads hyperautomation; no single AI leader | Not published; heavy Copilot use | Central oversight of grassroots AI; no published framework | Vendor-reported savings, no total | $383k |
| Thermo Fisher Scientific | 3 of 4 | CIO runs AI platform and governance | Not published; enterprise-wide AI literacy a priority | Responsible AI Framework; AI Technology Council | None published | $356k |
| UnitedHealth Group | 4 of 4 | CEO; Optum Insight CEO leads the AI build | Not published; daily AI use tracked for some Optum staff | AI review board of clinicians, data scientists and ethicists | Results by area and a 2:1 return target, no total | $1.15M |
Disclosure counts how many of the four strategy questions (where it is going, where it will focus, what it will take and how it will know it is working) a company answers in public. Fluency floor is the lowest level of AI fluency a company expects of all its people, on the five levels of the Lead with AI Fluency Matrix: Avoiding (0), Chatting (1), Collaborating (2), Integrating (3) and Transforming (4). The other columns summarize each company’s profile. Revenue per employee is for each company’s latest fiscal year, in US dollars. See all companies in the AI Strategy Index.
Frequently Asked Questions
What is Thermo Fisher’s AI strategy for its own work?
Thermo Fisher is embedding AI across its operations, products and services, with OpenAI as a partner for staff tools and clinical research. It has published no standalone AI strategy document for its own work.
Who leads AI at Thermo Fisher?
Chairman, President and CEO Marc Casper sets the direction, and the CIO’s organization runs the internal AI platform and governance. Ryan Snyder held the CIO role in 2025.
Which AI tools do Thermo Fisher employees use?
Thermo Fisher employees use ChatGPT Enterprise and an internal generative AI platform. The company prioritizes AI literacy across its workforce.
Is Thermo Fisher cutting jobs because of AI?
The sources reviewed show no AI-linked job cuts at Thermo Fisher. Headcount was about 125,000 at the end of 2025.
How is this profile put together?
Lead with AI profiles use public sources only, such as annual reports, earnings materials, filings and on-record interviews, dated at the time of writing. AI fluency is coded against the Lead with AI Fluency Matrix, and company figures are marked as company-claimed unless they have been independently verified.
About the AI Strategy Index
The Lead with AI AI Strategy Index profiles how the largest companies in the US and Europe approach AI, starting with the S&P 100 and the STOXX Europe 50. Each profile answers four questions: where the company is going with AI, where it will focus, what it will take and how it will know it is working. AI Pacesetters and notable companies outside the two indexes are profiled for contrast and are not counted. Profiles use public sources only, and AI fluency is coded against the Lead with AI Fluency Matrix.
See all company profiles